GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Cyclically Adjusted FCF per Share

Chong Kun Dang Pharmaceutical (XKRX:185750) Cyclically Adjusted FCF per Share : ₩3,596.54 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Chong Kun Dang Pharmaceutical's adjusted free cash flow per share for the three months ended in Mar. 2024 was ₩2,462.781. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩3,596.54 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-09), Chong Kun Dang Pharmaceutical's current stock price is ₩106700.00. Chong Kun Dang Pharmaceutical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩3,596.54. Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF of today is 29.67.

During the past 11 years, the highest Cyclically Adjusted Price-to-FCF of Chong Kun Dang Pharmaceutical was 33.73. The lowest was 27.58. And the median was 29.45.


Chong Kun Dang Pharmaceutical Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Cyclically Adjusted FCF per Share Chart

Chong Kun Dang Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 3,711.30

Chong Kun Dang Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 3,711.30 3,596.54

Competitive Comparison of Chong Kun Dang Pharmaceutical's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF falls into.



Chong Kun Dang Pharmaceutical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chong Kun Dang Pharmaceutical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2462.781/118.8477*118.8477
=2,462.781

Current CPI (Mar. 2024) = 118.8477.

Chong Kun Dang Pharmaceutical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -482.978 99.353 -577.746
201409 738.036 99.608 880.591
201412 0.307 99.098 0.368
201503 827.086 99.720 985.733
201506 -913.857 100.050 -1,085.555
201509 -326.923 100.110 -388.114
201512 -1,730.183 100.220 -2,051.769
201603 -149.775 100.560 -177.013
201606 -1,749.342 100.790 -2,062.757
201609 697.243 101.460 816.733
201612 2,587.388 101.560 3,027.817
201703 1,682.535 102.850 1,944.243
201706 -66.410 102.610 -76.919
201709 1,945.982 103.490 2,234.762
201712 780.749 102.990 900.963
201803 327.557 104.100 373.962
201806 -1,549.377 104.130 -1,768.365
201809 788.248 105.650 886.715
201812 2,146.540 104.350 2,444.766
201903 991.153 104.490 1,127.345
201906 481.437 104.880 545.554
201909 1,581.558 105.200 1,786.735
201912 915.405 105.120 1,034.948
202003 693.772 105.540 781.251
202006 1,401.165 104.870 1,587.921
202009 1,653.845 106.200 1,850.807
202012 1,409.230 105.765 1,583.540
202103 -621.557 107.357 -688.083
202106 647.447 107.579 715.269
202109 -63.670 108.759 -69.576
202112 -3,479.135 109.676 -3,770.065
202203 -360.269 111.806 -382.960
202206 1,429.597 114.083 1,489.307
202209 -583.981 114.831 -604.407
202212 607.398 115.200 626.630
202303 2,348.784 116.550 2,395.097
202306 1,661.879 117.140 1,686.108
202309 5,806.783 119.111 5,793.937
202312 9,704.842 118.848 9,704.842
202403 2,462.781 118.848 2,462.781

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Chong Kun Dang Pharmaceutical  (XKRX:185750) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=106700.00/3596.54
=29.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted Price-to-FCF of Chong Kun Dang Pharmaceutical was 33.73. The lowest was 27.58. And the median was 29.45.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Chong Kun Dang Pharmaceutical Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Traded in Other Exchanges
N/A
Address
368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756
Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines